Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant [0.03%]
自体干细胞移植患者在接受 melphalan治疗时在-1天与-2天给药的对比研究（多发性骨髓瘤及其他浆细胞疾病）
Aleksandra N Watson,Shreya A Shah,Sila D Shalhoub et al.
Aleksandra N Watson et al.
High-dose melphalan-based autologous stem cell transplant (ASCT) remains a standard of care for plasma cell disorders (PCDs). Currently, there is variability in the literature surrounding the timing of melphalan administration to avoid pote...
Investigation of the frequency of bortezomib neuropathy in patients with multiple myeloma diagnosis with normal and abnormal genetic characteristics [0.03%]
评估硼替佐米周围神经病变在具有正常和异常遗传特征的多发性骨髓瘤患者中的发病率调查
Ayse N Kul,Yildiz Ipek
Ayse N Kul
Introduction: Bortezomib-induced peripheral neuropathy in patients with multiple myeloma is an undesirable and sometimes severe side effect. Our study aimed to examine whether there was a difference in bortezomib-induced ...
Management of chemotherapy-induced febrile neutropenia and use of granulocyte colony-stimulating factor in patients with soft tissue or bone sarcoma [0.03%]
化疗引起的发热性中性粒细胞减少症的管理及粒细胞集落刺激因子在软组织或骨肉瘤患者中的应用
Raphaele Teixeira Mazzaro,Mahanna Vanzeler Vaz,Rebeka Caribé Badin et al.
Raphaele Teixeira Mazzaro et al.
Introduction: Febrile neutropenia, an oncological complication related to myelosuppressive chemotherapy, can lead to unplanned hospitalization, morbidity, mortality, and changes in the oncological therapeutic plan. The pr...
Automated chemotherapy compounding: Process optimization for the preparation of admixture containing high-dose of cyclophosphamide [0.03%]
化疗自动化配药：环磷酰胺高剂量混合调配制的工艺优化
Gianluca Perego,Giorgia Longobardo,Anna Baldisserotto et al.
Gianluca Perego et al.
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes [0.03%]
免疫检查点抑制剂的住院应用及其临床结局
Jonathan Wang,Chung-Shien Lee,Shirin Attarian et al.
Jonathan Wang et al.
Introduction: Retrospective studies have suggested that patients with poor performance status treated with immune checkpoint inhibitors have shorter overall survival and poorer response rates. This study was undertaken to...
Economic burden in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with or without brain metastases, receiving first-line ALK inhibitors [0.03%]
关于ROS1阳性非小细胞肺癌患者一线使用克唑替尼治疗的疗效和生存分析：针对脑转移患者的亚组分析
Yanyu Wu,Kaili Ren,Yin Wan et al.
Yanyu Wu et al.
Introduction: This observational study describes the real-world economic burden in patients with anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) receiving a first-line ALK inhibitor, and the e...
Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b [0.03%]
5-氟尿嘧啶治疗干扰素治疗无效的结膜原位癌的疗效及安全性研究
Pilar Pérez-García,Bárbara Burgos-Blasco,Verónica Gómez-Calleja et al.
Pilar Pérez-García et al.
Purpose: To report the efficacy and safety of 5-fluorouracil as the second line of treatment for two cases of conjunctival intraepithelial neoplasia refractive to topical interferon alpha-2b. ...
Björn M Beurer,Luise M Sprenger,Kristina Graneß et al.
Björn M Beurer et al.
Introduction: PARP (Poly ADP Ribose Polymerase) inhibitors are an effective maintenance therapy for various entities, such as BRCA (breast cancer gene) mutated or HRD (homologous recombination deficiency) positive primary...
Comparison of permeabilities of eight different types of cytotoxic drugs to five gloves with different materials by LC-MS/MS methods to reduce occupational exposure of medical personnel [0.03%]
液质联用法测定8种细胞毒性药物对5种不同材料医用手套的渗透性以减少医务人员职业暴露风险比较研究
Hailong Zhou,Yunyun Li,Fan Xu
Hailong Zhou
Purpose: Occupational exposure is a long-standing public health concern, which has drawn more and more attention in recent years to the problem of how to carry out occupational protection effectively. Gloves are regarded ...
Immune-related pneumonitis requiring low-dose prednisone maintenance in one patient with durable complete response [0.03%]
一例长期完全缓解的免疫相关性肺炎维持低剂量泼尼松治疗病例报告
Yu Zhou,Baozhen Ma,Tiepeng Li et al.
Yu Zhou et al.
Introduction: Immune-related pneumonitis is an uncommon but potentially life-threatening adverse event associated with anti-programmed cell death protein-1 therapy, and has a higher recurrence rate than that of other pneu...